Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
May 21, 2018
May 03, 2018
Jan. 18, 2018
May 31, 2018
Jun. 30, 2018
May 14, 2018
Dec. 31, 2017
Common stock authorized         800,000,000   800,000,000
Common stock par value         $ 0.001   $ 0.001
Common stock issued         29,923,000   24,275,000
Common stock outstanding         29,923,000   24,275,000
Gross proceeds from public offering   $ 8,000          
Net proceeds from public offering   $ 7,700          
Debt conversion converted instrument, shares issued 1,085,105            
Convertible note interest rate, percentage 8.00%            
Underwriter [Member] | Over-Allotment Option [Member]              
Number of warrants issued to purchase common shares           225,000  
October 27, 2018 [Member] | Underwriter [Member]              
Number of common shares sold         4,210,527    
Sale of stock price per share         $ 1.767    
Number of warrants issued to purchase common shares         84,211    
Warrant exercise price per share         $ 2.09    
Board of Directors [Member]              
Common stock reverse stock split     one-for-thirty reverse split        
Gross proceeds from public offering       $ 10,000      
Debt conversion converted instrument, shares issued       1,085,105      
Convertible note interest rate, percentage       8.00%      
Public [Member] | October 27, 2018 [Member] | Underwriter [Member]              
Sale of stock price per share         $ 1.90    
August 6, 2018 [Member]              
Common stock authorized         100,000,000    
Common stock par value         $ 0.001